Oguz Emrah, Ozturk Pelin, Erkul Sinan, Calkavur Tanzer
Department of Cardiovascular Surgery, Ege University Medical School Hospital, Izmir, Turkey.
Hemodial Int. 2012 Apr;16(2):306-9. doi: 10.1111/j.1542-4758.2011.00653.x.
The purpose of this study is to evaluate the efficacy and safety of direct right atrial catheter insertion for hemodialysis in patients with multiple venous access failure. We retrospectively evaluated the charts of 27 patients with multiple venous access failure who had intra-atrial dialysis catheter placement between October 2005 and October 2010 in our clinic. Permanent right atrial dialysis catheters were placed through a right anterior mini-thoracotomy under intratracheal general anesthesia in all patients. Demographics of the cases, the patency rates of hemodialysis via atrial catheterization, existence of any catheter thrombosis, and catheter-related infections were documented and used in statistical analysis. Seventeen women (63%) and 10 men (37%) with the mean age of 59.0 ± 7.1 years (47-71) were enrolled in this study. Chronic renal failure was diagnosed for the mean of 78.9 ± 24.3 months (33-130). Five patients (18.5%) died. Ventricular fibrillation and myocardial infarction were the causes of death in the early postoperative period in two patients. Two of the remaining three patients died because of cerebrovascular events, and one patient died because of an unknown cause. Ten patients (37%) had been using anticoagulate agents (warfarin) because of concomitant disorders such as deep vein thrombosis, operated valve disease, and arrhythmias. Catheter thrombosis and malfunction was determined in three cases (11.1%). Intra-atrial hemodialysis catheterization is a safe and effective life-saving measure for the patients with multiple venous failure and without any possibility of peritoneal dialysis or renal transplantation.
本研究的目的是评估直接右心房置管用于多静脉通路衰竭患者血液透析的有效性和安全性。我们回顾性评估了2005年10月至2010年10月在我院接受心房内透析导管置入的27例多静脉通路衰竭患者的病历。所有患者均在气管内全身麻醉下通过右前小切口置入永久性右心房透析导管。记录病例的人口统计学资料、经心房置管进行血液透析的通畅率、是否存在导管血栓形成以及导管相关感染情况,并用于统计分析。本研究纳入了17名女性(63%)和10名男性(37%),平均年龄为59.0±7.1岁(47 - 71岁)。慢性肾衰竭的诊断时间平均为78.9±24.3个月(33 - 130个月)。5例患者(18.5%)死亡。两名患者术后早期死于心室颤动和心肌梗死。其余三名患者中,两名因脑血管事件死亡,一名死因不明。10例患者(37%)因合并深静脉血栓形成、人工瓣膜病和心律失常等疾病而一直在使用抗凝剂(华法林)。3例患者(11.1%)出现导管血栓形成和功能障碍。对于多静脉衰竭且无腹膜透析或肾移植可能性的患者,心房内血液透析置管是一种安全有效的挽救生命的措施。